| Literature DB >> 15607132 |
Yoshiharu Shimomura1, Taro Murakami, Masaru Nagasaki, Takashi Honda, Hidemi Goto, Katsuhiro Kotake, Tsuyoshi Kurokawa, Toshiaki Nonami.
Abstract
Significant evidence of the pharmacological and physiological effects of branched-chain amino acids (BCAA) has accumulated, attracting the interest of not only clinicians but also basic medical researchers. We summarize here the characteristic features of BCAA catabolism, focusing on the initial two enzymes in the pathway, branched-chain aminotransferase and branched-chain alpha-keto acid dehydrogenase complex. In addition, we describe a unique characteristic of the valine catabolic pathway. Finally, we present evidence obtained in animal studies that indicates that BCAA treatment may be appropriate for liver cirrhosis, but not acute liver failure.Entities:
Year: 2004 PMID: 15607132 DOI: 10.1016/j.hepres.2004.09.001
Source DB: PubMed Journal: Hepatol Res ISSN: 1386-6346 Impact factor: 4.288